| 1 |
32762742 | An EGFR T790M-mutated lung adenocarcinoma undergoing large-cell neuroendocrine carcinoma transformation after osimertinib therapy: a case report. | 2020 Aug 7 |
1 |
| 2 |
31161851 | Unexpected favorable outcome to etoposide and cisplatin in a small cell lung cancer transformed patient: a case report. | 2019 |
1 |
| 3 |
25724377 | A Potential Epigenetic Therapy for NSCLC. | 2015 Apr |
1 |
| 4 |
25908039 | Transformation to small cell lung cancer as an acquired resistance mechanism in EGFR-mutant lung adenocarcinoma: a case report of complete response to etoposide and cisplatin. | 2015 Jun 25 |
1 |
| 5 |
23178489 | The role of insulin-like growth factor binding protein-3 in the breast cancer cell response to DNA-damaging agents. | 2014 Jan 2 |
1 |
| 6 |
24606760 | Interaction of translationally controlled tumor protein with Apaf-1 is involved in the development of chemoresistance in HeLa cells. | 2014 Mar 7 |
1 |
| 7 |
24092808 | Treatment with gefitinib or lapatinib induces drug resistance through downregulation of topoisomerase IIα expression. | 2013 Dec |
1 |
| 8 |
20395290 | HIF-2alpha-mediated activation of the epidermal growth factor receptor potentiates head and neck cancer cell migration in response to hypoxia. | 2010 Jul |
2 |
| 9 |
20929928 | Mitochondrially localized EGFR is independent of its endocytosis and associates with cell viability. | 2010 Nov |
1 |
| 10 |
18398293 | Mitochondrially localized EGFR is subjected to autophagic regulation and implicated in cell survival. | 2008 Jul |
1 |
| 11 |
17013895 | Novel combination therapy against metastatic and androgen-independent prostate cancer by using gefitinib, tamoxifen and etoposide. | 2007 Jan 1 |
3 |
| 12 |
17092291 | Inhibition of the epidermal growth factor receptor in bladder cancer cells treated with the DNA-damaging drug etoposide markedly increases apoptosis. | 2007 Jan |
5 |
| 13 |
16467098 | Herceptin sensitizes ErbB2-overexpressing cells to apoptosis by reducing antiapoptotic Mcl-1 expression. | 2006 Feb 1 |
1 |
| 14 |
16505093 | Interaction of the epidermal growth factor receptor and the DNA-dependent protein kinase pathway following gefitinib treatment. | 2006 Feb |
1 |
| 15 |
16322251 | Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells. | 2005 Dec 1 |
1 |
| 16 |
15273254 | Relationship between antiapoptotic molecules and metastatic potency and the involvement of DNA-dependent protein kinase in the chemosensitization of metastatic human cancer cells by epidermal growth factor receptor blockade. | 2004 Dec |
1 |
| 17 |
10226546 | Enhancement of chemosensitivity and programmed cell death by tyrosine kinase inhibitors correlates with EGFR expression in non-small cell lung cancer cells. | 1999 Jan-Feb |
1 |
| 18 |
7847819 | Effects of cytostatic agents on the expression of epidermal growth factor receptor in ovarian cancer cells. | 1994 Sep-Oct |
2 |